Global HER2 Targeted Therapy Market Research Report 2022 - Market Size, Current Insights and Development Trends

Global HER2 Targeted Therapy Market Research Report 2022 - Market Size, Current Insights and Development Trends

The report focuses on the HER2 Targeted Therapy market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the HER2 Targeted Therapy market.

Major Players in the HER2 Targeted Therapy market are:

Roche
GlaxoSmithKline
Astra Zeneca
Agilent
Daiichi Sankyo
Glenmark Pharmaceuticals
Novartis
Bayer
Abbott
Pfizer
Merck
Sanofi
AbbVie

On the basis of types, the HER2 Targeted Therapy market is primarily split into:

Monotherapy
Combination Therapy
Others

On the basis of applications, the market covers:

Breast Cancer
Stomach Cancer
Head and Neck Cancer
Lung Cancer
Ovarian Cancer
Others

Major Regions or countries covered in this report:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

Years considered for this report:

Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029


1 HER2 Targeted Therapy Market Overview
1.1 Product Overview and Scope of HER2 Targeted Therapy Market
1.2 HER2 Targeted Therapy Market Segment by Type
1.2.1 Global HER2 Targeted Therapy Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global HER2 Targeted Therapy Market Segment by Application
1.3.1 HER2 Targeted Therapy Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global HER2 Targeted Therapy Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of HER2 Targeted Therapy (2017-2029)
1.5.1 Global HER2 Targeted Therapy Market Revenue Status and Outlook (2017-2029)
1.5.2 Global HER2 Targeted Therapy Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the HER2 Targeted Therapy Industry
1.7 Impact of Carbon Neutrality on the HER2 Targeted Therapy Industry
2 HER2 Targeted Therapy Market Upstream and Downstream Analysis
2.1 HER2 Targeted Therapy Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of HER2 Targeted Therapy Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Roche
3.1.1 Roche Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.1.4 Business Overview
3.2 GlaxoSmithKline
3.2.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Astra Zeneca
3.3.1 Astra Zeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Agilent
3.4.1 Agilent Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Daiichi Sankyo
3.5.1 Daiichi Sankyo Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Glenmark Pharmaceuticals
3.6.1 Glenmark Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Novartis
3.7.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Bayer
3.8.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Abbott
3.9.1 Abbott Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Pfizer
3.10.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Merck
3.11.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Sanofi
3.12.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.12.4 Business Overview
3.13 AbbVie
3.13.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 HER2 Targeted Therapy Market Performance (2017-2022)
3.13.4 Business Overview
4 Global HER2 Targeted Therapy Market Landscape by Player
4.1 Global HER2 Targeted Therapy Sales and Share by Player (2017-2022)
4.2 Global HER2 Targeted Therapy Revenue and Market Share by Player (2017-2022)
4.3 Global HER2 Targeted Therapy Average Price by Player (2017-2022)
4.4 Global HER2 Targeted Therapy Gross Margin by Player (2017-2022)
4.5 HER2 Targeted Therapy Market Competitive Situation and Trends
4.5.1 HER2 Targeted Therapy Market Concentration Rate
4.5.2 HER2 Targeted Therapy Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global HER2 Targeted Therapy Sales, Revenue, Price Trend by Type
5.1 Global HER2 Targeted Therapy Sales and Market Share by Type (2017-2022)
5.2 Global HER2 Targeted Therapy Revenue and Market Share by Type (2017-2022)
5.3 Global HER2 Targeted Therapy Price by Type (2017-2022)
5.4 Global HER2 Targeted Therapy Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global HER2 Targeted Therapy Sales, Revenue and Growth Rate of Monotherapy (2017-2022)
5.4.2 Global HER2 Targeted Therapy Sales, Revenue and Growth Rate of Combination Therapy (2017-2022)
5.4.3 Global HER2 Targeted Therapy Sales, Revenue and Growth Rate of Others (2017-2022)
6 Global HER2 Targeted Therapy Market Analysis by Application
6.1 Global HER2 Targeted Therapy Consumption and Market Share by Application (2017-2022)
6.2 Global HER2 Targeted Therapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global HER2 Targeted Therapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global HER2 Targeted Therapy Consumption and Growth Rate of Breast Cancer (2017-2022)
6.3.2 Global HER2 Targeted Therapy Consumption and Growth Rate of Stomach Cancer (2017-2022)
6.3.3 Global HER2 Targeted Therapy Consumption and Growth Rate of Head and Neck Cancer (2017-2022)
6.3.4 Global HER2 Targeted Therapy Consumption and Growth Rate of Lung Cancer (2017-2022)
6.3.5 Global HER2 Targeted Therapy Consumption and Growth Rate of Ovarian Cancer (2017-2022)
6.3.6 Global HER2 Targeted Therapy Consumption and Growth Rate of Others (2017-2022)
7 Global HER2 Targeted Therapy Sales and Revenue Region Wise (2017-2022)
7.1 Global HER2 Targeted Therapy Sales and Market Share, Region Wise (2017-2022)
7.2 Global HER2 Targeted Therapy Revenue and Market Share, Region Wise (2017-2022)
7.3 Global HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa HER2 Targeted Therapy Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global HER2 Targeted Therapy Market Forecast (2022-2029)
8.1 Global HER2 Targeted Therapy Sales, Revenue Forecast (2022-2029)
8.1.1 Global HER2 Targeted Therapy Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global HER2 Targeted Therapy Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global HER2 Targeted Therapy Price and Trend Forecast (2022-2029)
8.2 Global HER2 Targeted Therapy Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States HER2 Targeted Therapy Sales and Revenue Forecast (2022-2029)
8.2.2 Europe HER2 Targeted Therapy Sales and Revenue Forecast (2022-2029)
8.2.3 China HER2 Targeted Therapy Sales and Revenue Forecast (2022-2029)
8.2.4 Japan HER2 Targeted Therapy Sales and Revenue Forecast (2022-2029)
8.2.5 India HER2 Targeted Therapy Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia HER2 Targeted Therapy Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America HER2 Targeted Therapy Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa HER2 Targeted Therapy Sales and Revenue Forecast (2022-2029)
8.3 Global HER2 Targeted Therapy Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global HER2 Targeted Therapy Revenue and Growth Rate of Monotherapy (2022-2029)
8.3.2 Global HER2 Targeted Therapy Revenue and Growth Rate of Combination Therapy (2022-2029)
8.3.3 Global HER2 Targeted Therapy Revenue and Growth Rate of Others (2022-2029)
8.4 Global HER2 Targeted Therapy Consumption Forecast by Application (2022-2029)
8.4.1 Global HER2 Targeted Therapy Consumption Value and Growth Rate of Breast Cancer (2022-2029)
8.4.2 Global HER2 Targeted Therapy Consumption Value and Growth Rate of Stomach Cancer (2022-2029)
8.4.3 Global HER2 Targeted Therapy Consumption Value and Growth Rate of Head and Neck Cancer (2022-2029)
8.4.4 Global HER2 Targeted Therapy Consumption Value and Growth Rate of Lung Cancer (2022-2029)
8.4.5 Global HER2 Targeted Therapy Consumption Value and Growth Rate of Ovarian Cancer (2022-2029)
8.4.6 Global HER2 Targeted Therapy Consumption Value and Growth Rate of Others (2022-2029)
8.5 HER2 Targeted Therapy Market Forecast Under COVID-19
9 Industry Outlook
9.1 HER2 Targeted Therapy Market Drivers Analysis
9.2 HER2 Targeted Therapy Market Restraints and Challenges
9.3 HER2 Targeted Therapy Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 HER2 Targeted Therapy Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 HER2 Targeted Therapy Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on HER2 Targeted Therapy Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings